Answers are grounded in this paper and cite their sources.
Influenza virus infection is a major trigger of acute exacerbations of chronic obstructive pulmonary disease (COPD), yet the cellular mechanisms linking antiviral defense to lung injury and recovery remain incompletely defined. COPD-associated epithelial remodeling, chronic inflammation, and impaired mucociliary clearance may alter host responses to infection, but do not necessarily produce a uniform defect in antiviral immunity. This review examines three interconnected processes in influenza-infected COPD lungs: viral control, immunopathology, and tissue repair. We discuss how airway epithelial dysfunction and altered innate immune signaling may affect viral sensing and interferon responses, and how inflammatory amplification and oxidative stress may contribute to tissue injury beyond viral replication itself. We also consider epithelial regeneration, restoration of mucociliary function, and inflammatory resolution in determining recovery after acute exacerbations. Particular emphasis is placed on the distinction between delayed recovery and long-term COPD progression, for which influenza-specific evidence remains limited. These mechanisms inform the potential and limitations of antiviral and host-directed interventions, highlighting the need to balance viral suppression with tissue protection. Integrating human airway models with longitudinal clinical studies may clarify disease-stage-dependent mechanisms and identify patients most likely to benefit from targeted treatment. A clearer understanding of viral control, inflammatory injury, and pulmonary repair may guide more precise strategies for influenza-associated COPD exacerbations.
No takes yet. Share an insight, caveat, or question.
Hui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: